Member Info for EXMEX

I don't know if this link has been posted before
https://www.who.int/diagnostics_laboratory/eual/listing/en/index1.html
It's from the WHO web site and takes you to the report's on the Covid-19 test's they have validated. Click on the Primer Design link and you'll get the full detail's

Politicians name should have read Nazir Chohan

https://chughtailab.com/coronavirus/
This is the lab in Lahore that completed the postal covid19 test on the Pakistan politician Nasir Fulham.They are part of a nationwide chain of over 300 lab's. On their website they advertise the Covid-19 test but don't give detail's of the supplier .However the documentation on the video clip clearly shows Genesig-covid-19 real time PCR test and is date and time stamped earlier this morning. The lab in Lahore also appear to operate three drive through testing station's in Lahore.

https://messageboardfools.com/bashers.htm

https://messageboardfools.com/Bashers.htm

The outlook for Africa doesn't look good with the number of new cases increasing as the virus continues to spread inexorably. Several countries have limited testing taking place ,but overall there is a serious shortage of reagents ,tests and equipment.
https://www.thenewhumanitarian.org/news2020/05/18/Africa-coronavirus-test-kits

It certainly appears that the m+m's have parked the share price at around the £2.50 mark while they offload the Vagel shares onto the market. From this price it is easy for them to take the brakes off slightly and let market demand absorb reasonable sized tranches before working the price back down again. It looks like roughly 100,000 were put through this morning between 10.30 and 11.00 . Vagel took 811,988 shares without a lock in period to make sure they can get the full amount of money owed to them ( 2,066,257 euro's) immediately .A share price around £2.50 cover's this and any other expenses and dealing charges incurred.

Who's going to help Novacyt produce those new reagents?

Klopp, I don't know if you saw my post from last week about the respiratory diseases market. Last November Novacyt designed and launched a multiplex respiratory test which tests for 37 different pathogen's. This is currently being used and marketed by their US partner.

See if this link works
https://audiobook.com/posts/7597926-arix-bioscience-and-vadim-alexandre-on-novacyt-genedrive-omega-diagnostics-avacta
Interview 16 minutes in

Parkez, currently there is a global shortage of the traditional reagents that laboratories use in the PCR RNA extraction process .What Novacyt have done is develop a new Exsig Mag reagent as an alternative choice to those reagents in short supply. The Exsig direct product is a different approach to this problem that will provide laboratories with the means to extract RNA from test swab's before starting the PCR process. The advantage of doing the extraction this way is it will save a considerable amount of time and mean labs can process more test's. There should be a significant demand for these two new product's once they are launched this month
It's also worth noting that today's sales figures only relate to Covid-19 test sales . During the last three months Novacyt has been recruiting staff across the group, a good indication that Microgen , Lab21 and Primer Design are all busy .

Troublesome,I see Worldmeter were provided with the new figures for yesterday's death rates just after 18.00. It seems rather convenient timing. Last week on the 26th the figures stated there had been a sharp rise in in new positive cases to over 4,000. When I looked the following day half of these had been reallocated to may 20th. That's one way of making the seven average look like it's going in the right direction.

I notice that Primer Design have increased the price of the genesig q16 to £6,500 .

I don't know if this has been posted before
https://www.rapidmicrobiology.com/news/who-release-covid-19-test-scores-of-100

https://www.euronext.com/en/trade/trading-hours-holidays
Hope this link helps

I see Genesis Diagnostics in the USA are advertising Covid-19 testing for $99 using Primer Design tests.
https://genesisdx.com/
They are the partner in the USA who Novacyt designed a multiplex respiratory test panel for ,that was mentioned in the recent year end rns . If you look on their web site there is only one of this type of test showing with full details of all the pathogen's it tests for .
In the recent rns GM used figures from 2016 for the size of the global respiratory testing market of $5 billion . These are way of date and the market had already increased to $10 billion by 2019 .With the onset of the Covid-19 pandemic and the damage it can cause to lung function this market will grow considerably.
https://www.gminsights.com/industry-analysis/respiratory-disease-testing-market

On the 20/05/20 the Egyptian government announced they were scaling up testing and making test's available in all 320 of their general hospital's.
https://uk.reuters.com/article/us-health-coronavirus-egypt/egypt-to-offer-coronavirus-testing-in-all-general-hopitals-idUKKBN22W2UI

Just been looking through the interim result's that came out last September. I don't know if it's been posted before regarding the q16 and q32 PCR platform's that Novacyt sell .A statement in the result's say's - further operational enhancement's to both the q16 and q32 instrument platform's are planned in 2020 to provide gold standard PCR cycle times of 30 minutes.
It appears that Novacyt were already aiming to halve the operational time for their two PCR testing platform's .

This is the mobile PCR machine they are talking of using . Extremely portable and capable of 16 test's at the same time .
https://www.genesig.com/products/9696-the-genesig-q16

https://www.morningstar.co.uk/uk/news/AN_1586439122041824500/covid-19-antibody-test-could-be-scaled-up-by-may-end-says-astrazeneca.aspx